Four-year outcomes from a multiparametric magnetic resonance imaging (MRI)-based active surveillance programme: PSA dynamics and serial MRI scans allow omission of protocol biopsies.
Kevin Michael GallagherEdward ChristopherAndrew James CameronScott LittleAlasdair InnesGill DavisJulian KeaniePrasad BollinaAlan McNeillPublished in: BJU international (2018)
Men with low-risk Gleason 3 + 3 prostate cancer on active surveillance can forgo protocol biopsies in favour of MRI and PSA monitoring with selective re-biopsy.